LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$52.76

Market cap

$2.85B

P/E Ratio

159.88

Dividend/share

N/A

EPS

$0.33

Enterprise value

$2.9B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's EPS has surged by 120% YoY
The net income has soared by 120% YoY
LIVN's debt is up by 11% year-on-year and by 3.2% since the previous quarter
LivaNova's gross margin has decreased by 3.3% YoY and by 2.2% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: OFIX NVRO NURO

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
53.96M
Market cap
$2.85B
Enterprise value
$2.9B
Valuations
Price to earnings (P/E)
159.88
Price to book (P/B)
2.22
Price to sales (P/S)
2.47
EV/EBIT
N/A
EV/EBITDA
75.59
EV/Sales
2.51
Earnings
Revenue
$1.15B
EBIT
-$22.48M
EBITDA
$38.38M
Free cash flow
$39.93M
Per share
EPS
$0.33
Free cash flow per share
$0.74
Book value per share
$23.72
Revenue per share
$21.39
TBVPS
$25.69
Balance sheet
Total assets
$2.43B
Total liabilities
$1.15B
Debt
$632.04M
Equity
$1.28B
Working capital
$653.18M
Liquidity
Debt to equity
0.49
Current ratio
2.95
Quick ratio
2.37
Net debt/EBITDA
1.41
Margins
EBITDA margin
3.3%
Gross margin
66.9%
Net margin
1.5%
Operating margin
-5.9%
Efficiency
Return on assets
0.7%
Return on equity
1.4%
Return on invested capital
-2.3%
Return on capital employed
-1.1%
Return on sales
-1.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
1.72%
1 week
-2.42%
1 month
3.94%
1 year
10.4%
YTD
1.97%
QTD
-5.68%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.15B
Gross profit
$771.25M
Operating income
-$68.5M
Net income
$17.55M
Gross margin
66.9%
Net margin
1.5%
The net income has soared by 120% YoY
LIVN's net margin has soared by 118% year-on-year
LivaNova's operating margin has increased by 21% YoY
LivaNova's revenue has increased by 13% YoY and by 3.2% from the previous quarter

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
LIVN P/E details
P/E
159.88
P/B
2.22
P/S
2.47
EV/EBIT
N/A
EV/EBITDA
75.59
EV/Sales
2.51
LivaNova's EPS has surged by 120% YoY
The price to book (P/B) is 15% lower than the 5-year quarterly average of 2.6
The equity rose by 6% year-on-year and by 4.3% since the previous quarter
The price to sales (P/S) is 20% lower than the 5-year quarterly average of 3.1 but 2.9% higher than the last 4 quarters average of 2.4
LivaNova's revenue has increased by 13% YoY and by 3.2% from the previous quarter

Efficiency

How efficient is LivaNova business performance
The ROIC has plunged by 129% from the previous quarter but it has grown by 23% YoY
LivaNova's return on sales has shrunk by 128% QoQ but it has increased by 27% YoY
The return on equity has surged by 120% year-on-year
The company's return on assets has surged by 119% YoY

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 111% higher than its total liabilities
The current ratio has declined by 9% since the previous quarter
LivaNova's total liabilities has increased by 6% YoY and by 4.3% QoQ
LIVN's debt is 51% smaller than its equity
LIVN's debt is up by 11% year-on-year and by 3.2% since the previous quarter
The equity rose by 6% year-on-year and by 4.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.